---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-014589"
form_type: "8-K"
ticker: "CC"
cik: "0001627223"
company_name: "Chemours Co"
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:26:07.807258+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Chemours reschedules Q4/FY 2023 earnings; cites internal control evaluation and Audit Committee review

## Summary
- Earnings release postponed from Feb 14 to Feb 28, 2024; conference call moved to Feb 29.
- Company needs extra time to complete year-end reporting; evaluating internal controls over financial reporting.
- Audit Committee conducting an internal review related to information and communications.
- Annual Report on Form 10-K expected to be filed by Feb 29, 2024.

## SEC filing metadata
- accession: 0000950170-24-014589
- form_type: 8-K
- ticker: CC
- cik: 0001627223
- company_name: Chemours Co
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1627223/000095017024014589/0000950170-24-014589-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1627223/000095017024014589/cc-20240213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-014589
- JSON: https://secwatch.observer/filing/0000950170-24-014589.json
- Plain text: https://secwatch.observer/filing/0000950170-24-014589.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.